| ≥ 5 Medications | ≥ 10 Medications | ≥ 15 Medications | |
|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| CP only vs. without CP | |||
| Model 1 | 1.39 (1.30-1.49) | 1.36 (1.26-1.47) | 1.35 (1.23-1.49) |
| Model 1 + race | 1.38 (1.29-1.48) | 1.35 (1.26-1.46) | 1.35 (1.22-1.49) |
| CP + NDDs vs. without CP | |||
| Model 1 | 2.52 (2.26-2.80) | 2.23 (2.00-2.49) | 1.59 (1.38-1.83) |
| Model 1 + race | 2.50 (2.24-2.78) | 2.22 (1.99-2.48) | 1.58 (1.38-1.82) |
| CP + NDDs vs. CP only | |||
| Model 1 | 1.81 (1.60-2.06) | 1.64 (1.43-1.87) | 1.17 (0.99-1.39) |
| Model 1 + race | 1.81 (1.59-2.06) | 1.64 (1.43-1.87) | 1.17 (0.99-1.39) |
Note: Model 1: age (as continuous), sex, U.S. region of residence, and multimorbidity.
a The without CP group served as the reference group.
CI = confidence interval; CP = cerebral palsy; NDD = neurodevelopmental disabilities; OR = odds ratio.